Common Contracts

AMENDED AND RESTATED COMBINATION AGREEMENT between COVALENT GROUP, INC. (“Covalent”) and Kai Lindevall Jan Lilja Sven-Erik Nilsson Vesa Manninen Seppo Oksanen Heikki Vapaatalo Riitta Korpela Agneta Lindevall NTGLT Pharma BVBA (the “Stockholders”)...

Combination Agreement • July 7th, 2006 • Covalent Group Inc • Services-commercial physical & biological research • Delaware

• Contract Type
  Combination Agreement
• Filed
  July 7th, 2006
• Company
  Covalent Group Inc
• Industry
  Services-commercial physical & biological research
• Jurisdiction
  Delaware

THIS AMENDED AND RESTATED COMBINATION AGREEMENT (the “Agreement”), made this 6th day of July, 2006 (the “Execution Date”), by and between Covalent Group, Inc., a Delaware corporation (“Covalent”) and Kai Lindevall, Jan Lilja, Sven-Erik Nilsson, Vesa Manninen, Seppo Oksanen, Heikki Vapaatalo, Riitta Korpela, NTGLT Pharma BVBA and Agneta Lindevall (each individually, a “Stockholder” and together, the “Stockholders”).

COMBINATION AGREEMENT between COVALENT GROUP, INC. (“Covalent”) and Kai Lindevall Jan Lilja Sven-Erik Nilsson Vesa Manninen Seppo Oksanen Heikki Vapaatalo Riitta Korpela Agneta Lindevall NTGLT Pharma BVBA (the “Stockholders”) dated March 2, 2006

Combination Agreement • March 29th, 2006 • Covalent Group Inc • Services-commercial physical & biological research • Delaware

• Contract Type
  Combination Agreement
• Filed
  March 29th, 2006
• Company
  Covalent Group Inc
• Industry
  Services-commercial physical & biological research
• Jurisdiction
  Delaware

THIS COMBINATION AGREEMENT (the “Agreement”), made this 2nd day of March, 2006 (the “Execution Date”), by and between Covalent Group, Inc., a Delaware corporation (“Covalent”) and Kai Lindevall, Jan Lilja, Sven-Erik Nilsson, Vesa Manninen, Seppo Oksanen, Heikki Vapaatalo, Riitta Korpela, NTGLT Pharma BVBA and Agneta Lindevall (each individually, a “Stockholder” and together, the “Stockholders”).